COCRYSTAL PHARMA, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $1.34 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2016-11-09
- COCRYSTAL PHARMA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2016-09-30 was $271.00K, a 65.24% increase year-over-year.
- COCRYSTAL PHARMA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2016-06-30 was $1.57M.
- COCRYSTAL PHARMA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2016-03-31 was -$497.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2015-09-30 was $164.00K, a 256.52% increase year-over-year.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 87 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.84M derived: sum of 2 quarters · filed 2016-11-09 | $1.34M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $1.07M 10-Q · filed 2016-08-09 | ||||
| 2016-03-31 | -$497.00K 10-Q · filed 2016-05-10 | |||||
| 2015-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $137.00K derived: sum of 2 quarters · filed 2016-11-09 | -$362.00K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$526.00K 10-Q · filed 2016-08-09 | ||||
| 2015-03-31 | -$499.00K 10-Q · filed 2016-05-10 | |||||
| 2014-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $52.00K derived: sum of 2 quarters · filed 2015-11-16 | $358.00K 10-Q · filed 2015-11-16 | |||
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $312.00K 10-Q · filed 2015-08-14 | -$312.00K 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | $306.00K 10-Q · filed 2015-05-14 | -$306.00K 10-Q · filed 2014-05-15 | $57.00K 10-Q · filed 2014-05-15 | |||
| 2013-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $44.00K derived: sum of 2 quarters · filed 2014-11-14 | $45.00K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$33.00K 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |